⌘K

Home/Filings/4/0001104659-25-004569

4//SEC Filing

Ali Asif 4

Accession 0001104659-25-004569

CIK 0001377121other

View on SEC.gov Company Profile

Filed

Jan 16, 7:00 PM ET

Accepted

Jan 17, 5:45 PM ET

Size

6.5 KB

Accession

0001104659-25-004569

Insider Transaction Report

Form 4

Period: 2025-01-16

Protagonist Therapeutics, IncPTGX

Chief Financial Officer

Transactions

Sale
Common Stock
2025-01-16−1,317→ 65,422 total
Sale
Common Stock
2025-01-16−2,601→ 62,821 total

Footnotes (1)

[F1]Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units.

Documents

1 file

4
tm253633-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Protagonist Therapeutics, Inc

CIK 0001377121

Entity typeother

Related Parties

1

filerCIK 0001921163

Filing Metadata

Form type: 4
Filed: Jan 16, 7:00 PM ET
Accepted: Jan 17, 5:45 PM ET
Size: 6.5 KB

View on SEC.gov